Pain Management Therapy Market
Pain Management Therapy Market - Global Industry Assessment & Forecast
#
Pages:
145
2022
Aug - 2023
VMR-VMR-2021-0199
Segments Covered
By
Type Drugs , Devices
-
By
Application Neuropathic Pain , Cancer Pain , Facial Pain and Migraine , Musculoskeletal Pain , Others
-
By
Mode of purchase Prescription, Over the counter
-
By
Region North America, Europe, Asia pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 70.9 Billion |
 Revenue 2030:
|
USD 97.77 Billion |
 Revenue CAGR
(2023 - 2030): |
4.1% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Research Methodology: Pain Management Therapy Market by Type by Application by Mode of purchase by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
Data Triangulation and Market Size Estimations
FAQ
Frequently Asked Question
What is the global demand for Pain Management Therapy in terms of revenue?
-
The global Pain Management Therapy valued at USD 70.9 Billion in 2022 and is expected to reach USD 97.77 Billion in 2030 growing at a CAGR of 4.1%.
Which are the prominent players in the market?
-
The prominent players in the market are Medtronic PLC, Teva Pharmaceutical Industries Ltd, Baxter International Inc., Novartis AG, Becton Dickinson & Company, Abbott Laboratories, Johnson & Johnson, Boston Scientific Corporation, GlaxoSmithKline PLC, Pfizer, AstraZeneca, Fresenius SE & Co. KGaA..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 4.1% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Pain Management Therapy include
- Rising prevalence of chronic pain conditions
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Pain Management Therapy in 2022.
